CompletedPhase 3NCT00294658
Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Studying Adult-onset myasthenia gravis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- Gary Cutter, PhDUniversity of Alabama at Birmingham School of Public Health, Department of Biostatistics
- Intervention
- thymectomy plus prednisone(procedure)
- Enrollment
- 126 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2006 – 2015
Study locations (30)
- University of Alabama at Birmingham, Department of Neurology, Sparks Center, Suite 350, 1720 7th Avenue South, Birmingham, Alabama, United States
- Data Coordination Center: University of Alabama at Birmingham, Birmingham, Alabama, United States
- Barrow Neurological Institute, Saint Joseph's Hospital and Medical Center, 350 W Thomas Rd, Phoenix, Arizona, United States
- University of Southern California, Doheny Institute, 1450 San Pablo St, Los Angeles, California, United States
- University of California Irvine, 101 The City Drive S, Bldg. 22 C, Route 13, Orange, California, United States
- California Pacific Medical Center, Castro St & Duboce Ave, San Francisco, California, United States
- University of Florida Jacksonville, Tower I, 8th Floor, 580 W. 8th ST., Jacksonville, Florida, United States
- University of Miami, 1120 NW 14th Street, Suite 1300, Miami, Florida, United States
- Emory University, 201 Dowman Dr, Atlanta, Georgia, United States
- Augusta University, 1120 15th St, Augusta, Georgia, United States
- Indiana University, Dept of Neurology, Regenstrief Health Center, 6th floor, 1050 Walnut St, Indiana University Medical Center, Indianapolis, Indiana, United States
- The University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, Kansas, United States
- Brigham and Women's Hospital, 75 Francis Street, 5th Floor Tower, Boston, Massachusetts, United States
- Wayne State University School of Medicine, 4201 St Antoine, 8D UHC, Detroit, Michigan, United States
- William Beaumont Hospital, 3601 W. Thirteen Mile Road, Royal Oak, Royal Oak, Michigan, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00294658 on ClinicalTrials.govOther trials for Adult-onset myasthenia gravis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06987539A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)Amgen
- RECRUITINGPHASE2NCT07501702A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia GravisVertex Pharmaceuticals Incorporated
- RECRUITINGPHASE1NCT07526493Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.Tongji Hospital
- RECRUITINGNANCT07413835Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)The Affiliated Hospital of Xuzhou Medical University
- RECRUITINGPHASE1, PHASE2NCT07089121Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune DisordersCartesian Therapeutics
- RECRUITINGPHASE1NCT07304154A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesKite, A Gilead Company
- RECRUITINGPHASE4NCT07221838A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With RavulizumabAlexion Pharmaceuticals, Inc.
- RECRUITINGPHASE1, PHASE2NCT07250750A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia GravisImmunAbs Inc.